National Institute of Allergy and Infectious Diseases (NIAID): HIV Seropositivity trials

The registry lists 15 HIV Seropositivity studies with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor. 0 are open to participants now and 1 have results posted.

Phase 1 6Phase 2 3Phase 4 1No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral TherapyCompletedNCT00367458Phase 2Results posted
• Prevalence and Incidence of Lassa Virus Infection in Southern MaliCompletedNCT03783143
• Immunogenicity of the 9-Valent Human Papillomavirus Recombinant Vaccine in People With Idiopathic CD4 T Cell LymphocytopeniaActive, not recruitingNCT03519464Phase 2
• Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected AdultsCompletedNCT00776412
• Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDSCompletedNCT00106795
• Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal FatCompletedNCT00009555Phase 4
• Safety and Tolerability of the Vaginal Gel PRO 2000/5CompletedNCT00006207Phase 1
• Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive PatientsCompletedNCT00001474Phase 2
• The Effect of Anti-HIV Therapy on Fat Metabolism in HIV-Positive PatientsCompletedNCT00001102
• A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive IndividualsCompletedNCT00000772Phase 1
• A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARCCompletedNCT00000735Phase 1
• A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ CellsCompletedNCT00000667Phase 1
• Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic IndividualsCompletedNCT00000664Phase 1
• A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive IndividualsCompletedNCT00000648Not applicable
• A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive IndividualsCompletedNCT00000633Phase 1